<p>Akoya Biosciences Inc. held a special meeting of stockholders on July 7, 2025. Stockholders approved the proposal to adopt the Amended and Restated Agreement and Plan of Merger involving Quanterix Corporation, Wellfleet Merger Sub, Inc., and Akoya Biosciences, Inc. Additionally, stockholders approved the proposal to adjourn the meeting if necessary to solicit additional proxies for the merger proposal. However, since the merger proposal was approved, the meeting was not adjourned. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akoya Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-066074), on July 07, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

AKYA

QTRX

<p>Akoya Biosciences Inc. held a special stockholders meeting on July 7, 2025, where stockholders approved the merger proposal with Quanterix Corporation and Wellfleet Merger Sub, Inc. The meeting was not adjourned as the merger proposal was successfully approved. This information was published via EDGAR by Akoya Biosciences Inc.</p>

Akoya Biosciences Inc. Conducted Special Stockholders Meeting